EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Long-Term Efficacy and Safety of Stapokibart in Patients with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Pivotal Phase 3 Trial

Sunday 02 Jun, 15:24 PM - 15:36 PM Valencia, Spain